(Q28287241)

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Genomic instability in laminopathy-based premature aging

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Köbberling type of familial partial lipodystrophy: an underrecognized syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Phenomics, lipodystrophy, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Post-mortem findings in familial partial lipodystrophy, Dunnigan variety

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Premature atherosclerosis associated with monogenic insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Type A insulin resistance syndrome revealing a novel lamin A mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

The strange case of the "lumper" lamin A/C gene and human premature ageing

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

LMNA mutations in atypical Werner's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Leptin-replacement therapy for lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021

Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970227-6

7 January 2021